- Home
- ELVN vs MTX Comparison
ELVN vs MTX Comparison
Compare ELVN & MTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | MTX |
|---|---|---|
| Founded | 2016 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2020 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ELVN | MTX |
|---|---|---|
| Price | $49.94 | $74.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $43.40 | ★ $82.00 |
| AVG Volume (30 Days) | ★ 2.3M | 255.2K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.68% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $2,072,600,000.00 |
| Revenue This Year | N/A | $5.66 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $63.64 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.79 | $53.94 |
| 52 Week High | $52.39 | $84.34 |
Technical Indicators
Market Signals| Indicator | ELVN | MTX |
|---|---|---|
| Relative Strength Index (RSI) | 64.02 | 42.82 |
| Support Level | $17.89 | $74.20 |
| Resistance Level | N/A | $74.92 |
| Average True Range (ATR) | 3.35 | 2.18 |
| MACD | 0.60 | -0.48 |
| Stochastic Oscillator | 80.81 | 20.26 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About MTX Minerals Technologies Inc.
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.